Description: Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
Home Page: www.genfit.com
Parc EurasantE
Loos,
59120
France
Phone:
33 3 20 16 40 00
Officers
| Name | Title |
|---|---|
| Mr. Jean-Francois Mouney | Co-Founder & Chairman of the Board |
| Mr. M. Pascal Prigent | Chief Executive Officer |
| Prof. Bart Staels | Co-Founder & Chairman of the Scientific Advisory Board |
| Mr. Thomas Baetz | Chief Financial Officer |
| Mr. Pascal Caisey | Chief Operating Officer |
| Dr. Meriam Kabbaj Ph.D. | Chief Technology Officer |
| Dr. Dean W. Hum Ph.D. | Chief Scientific Officer |
| Mr. Jean-Christophe Marcoux | Chief Corporate Affairs Officer, Head of Investor Relations & Head of ESG |
| Mr. Laurent Lannoo | Corporate Secretary & Director of Legal Affairs |
| Ms. Stefanie Magner J.D. | Chief Compliance Officer & Executive VP of International Legal Affairs |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 9.4518 |
|---|---|
| Trailing PE: | 14.2308 |
| Price-to-Book MRQ: | 2.7164 |
| Price-to-Sales TTM: | 3.4419 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 169 |